Central pancreatectomy for benign or low-grade malignant pancreatic tumors in the neck and body of the pancreas

Table 1 Demographic and clinical characteristics of the patients

	Central pancreatectomy (n = 34)	Distal pancreatectomy (n = 262)	P value
Gender			0.627
Female, n (%)	25 (73.5)	182 (69.5)
Male, n (%)	9 (26.5)	80 (30.5)
Age (x ± s, yr)	48 ± 13	52 ± 15	0.172
BMI (x ± s, kg/m2)	22.4 ± 3.4	22.8 ± 3.6	0.545
Hypertension, n (%)	7 (20.6)	78 (29.8)	0.266
Diabetes, n (%)	2 (5.9)	28 (10.7)	0.568
Tumor size (x ± s, cm)	3.2 ± 1.8	3.5 ± 2.1	0.433
Pathology, n (%)			< 0.005
SCN	13 (38.2)	48 (18.3)
IPMN	4 (11.8)	47 (17.6)
MCN	1 (2.9)	50 (19.1)
SPN	13 (38.2)	52 (19.8)
pNET	3 (8.8)	50 (19.1)
Median distance between the tumor and left-side border of the SMV (mm)	8.9 (10.9)	12.5 (11.4)	0.076

BMI: Body mass index; SCN: Serous cystic neoplasm; IPMN: Intraductal papillary mucinous neoplasm; MCN: Mucinous cystic neoplasm; SPN: Solid pseudopapillary neoplasm; pNET: Pancreatic neuroendocrine tumor; SMV: Superior mesenteric vein.